Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage ... News-Medical.net The 90-patient, placebo-controlled, randomized double-blinded Phase II study is evaluating the safety and efficacy for JVS-100 in patients with late stage heart failure. Dr. Amit Patel, the Director of Clinical Regenerative Medicine at University of ... |
